|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Köhler, Bianca; Dubovik, Sviatlana; Hörterer, Elisa; Wilk, Ulrich; Stöckl, Jan Bernd; Tekarslan-Sahin, Hande; Ljepoja, Bojan; Paulitschke, Philipp; Fröhlich, Thomas; Wagner, Ernst und Roidl, Andreas
(2022):
Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification.
In: Cancers, Bd. 14, Nr. 22
[PDF, 4MB]
Ljepoja, Bojan; Schreiber, Christoph; Gegenfurtner, Florian A.; Garcia-Roman, Jonathan; Köhler, Bianca; Zahler, Stefan; Rädler, Joachim O.; Wagner, Ernst und Roidl, Andreas
(2019):
Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A.
In: PLOS One 14(11), e0224314 [PDF, 2MB]
In: PLOS One 14(11), e0224314 [PDF, 2MB]
Sommer, Ann-Katrin; Falcenberg, Mathias; Ljepoja, Bojan; Fröhlich, Thomas; Arnold, Georg J.; Wagner, Ernst und Roidl, Andreas
(2019):
Downregulation of GRK5 hampers the migration of breast cancer cells.
In: Scientific Reports, Bd. 9, 15548
[PDF, 5MB]
Ljepoja, Bojan; Garcia-Roman, Jonathan; Sommer, Ann-Katrin; Wagner, Ernst und Roidl, Andreas
(2019):
MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
In: Breast, Bd. 43: S. 31-38
Ljepoja, Bojan; Garcia-Roman, Jonathan; Sommer, Ann-Katrin; Frohlich, Thomas; Arnold, Georg J.; Wagner, Ernst und Roidl, Andreas
(2018):
A proteomic analysis of an in vitro knock-out of miR-200c.
In: Scientific Reports, Bd. 8, 6927
[PDF, 3MB]
Sommer, Ann-Katrin; Hermawan, Adam; Ljepoja, Bojan; Fröhlich, Thomas; Arnold, Georg J.; Wagner, Ernst und Roidl, Andreas
(2018):
A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF-7 breast cancer cells.
In: International Journal of Molecular Medicine, Bd. 42, Nr. 4: S. 1987-1997
Sommer, Ann-Katrin; Hermawan, Adam; Mickler, Frauke Martina; Ljepoja, Bojan; Knyazev, Pjotr; Bräuchle, Christoph; Ullrich, Axel; Wagner, Ernst und Roidl, Andreas
(2016):
Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases.
In: Oncotarget, Bd. 7, Nr. 31: S. 50461-50476